SLSN

8-K - SOLESENCE, INC. (0000883107) (Filer)

8-K - SOLESENCE, INC. (0000883107) (Filer)

Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically driven health care solutions across beauty and life science categories, today reported its financial results for the second quarter ended June 30, 2026. "In the second quarter, our business focused on operational execution and financial discipline as we continue implementing our Transform and Transcend strategy," said Kevin Cureton, President and Chief Executive Officer. "By leveraging our intellectual property to enter high-growth markets, and expanding our co-marketing initiatives, we are

10-Q - SOLESENCE, INC. (0000883107) (Filer)

NT 10-Q - SOLESENCE, INC. (0000883107) (Filer)

ROMEOVILLE, Ill., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast. The additional time will allow the Company to complete its quarterly financial reporting and review process. The conference call and webcast will occur on Wednesday, August 19, 2026, at 5:00 p.m. ET. Second Quarter 2026 Conference Call DetailsDate/Time: Wednesday, August 19, 2026 – 4:00 p.m. CT, 5:00 p.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Office

ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date. Second Quarter 2026 Conference Call DetailsDate/Time: Tuesday, August 11, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/ecgoveo8/ Dial-In Link: https://register-conf.media-serv

New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen Scalp Screen Dry Shampoo SPF 45+ Sunscreen Named a Finalist for the 2026 Cosmopack Award for Best Formulation at Cosmoprof Las Vegas ROMEOVILLE, Ill., July 13, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the launch of two new market-ready products: Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen. Both products are available to brand partners globally and represent a significant expansion into the fa

8-K - SOLESENCE, INC. (0000883107) (Filer)

Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, has been named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards. Presented by HPCi Media, the Cosmetics Business Innovation Awards recognize and celebrate the most important innovations driving progress across the global cosmetics and personal care supply chain. The B2B-focused awards program spotlights the very best in ingredients, packaging, contract manufacturing, technology, testing, regula

       SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin ROMEOVILLE, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that its prototype product, Day Mode Hero Concealer SPF 50+, has won across three prototype product/chassis categories at the 2026 Cosmetics & Toiletries (C&T) Allē Awards: Anti-Aging, Color Cosmetics, and Compromised Skin. These awards mark Solésence's fourth year of recognition at the Allē Awards since 2022. Day Mode Hero Concealer SPF 50+ leverages three p

The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation. From left the photo includes: Carolyn Harris, MP, Chair of the APPG for Beauty, Hair & Wellbeing, Victoria Brownlie MBE, Chief Policy & Sustainability Officer, British Beauty Council, Emma Harper, Executive Director, Strategy, Marketing, and Communications, Solésence, Jacqui Burchell, Chief Commercial Officer (CCO), British Beauty Council. ROMEOVILLE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifica

10-Q - SOLESENCE, INC. (0000883107) (Filer)

8-K - SOLESENCE, INC. (0000883107) (Filer)

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026. "In March, we introduced Transform and Transcend to our investor community, the strategic initiative that we began at the end of 2025," commented Kevin Cureton, President and Chief Executive Officer. "Our first quarter results reflect our disciplined execution on this initiative, particularly on o

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment ROMEOVILLE, Ill., May 11, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the commercial availability of two proprietary platform technologies: WHSPR™ and Chromalüm™. Both technology platforms are available through finished goods for brand partners globally, and represent a significant expansion of the Company's ingredient technology portfolio. The launch of WHSPR™ and Chromalüm™ adv

8-K - SOLESENCE, INC. (0000883107) (Filer)

ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2026 after the market opens on Tuesday, May 12, 2026, and host a conference call and webcast on the same date. First Quarter 2026 Conference Call DetailsDate/Time: Tuesday, May 12, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/t9uyyvcs Dial-In Link: https://register-conf.media-server.com/re

Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the appointment of Marc James to its Board of Directors as an independent director, effective immediately. James will also serve as a member of the Company's Audit Committee, Compensation Committee, and Nominating Committee. The appointment reflects Solésence's continued focus on maintaining its strong corporate governance and enhancing board expertise as the Company advances its Transform & Tran

10-K/A - SOLESENCE, INC. (0000883107) (Filer)

10-K - SOLESENCE, INC. (0000883107) (Filer)

8-K - SOLESENCE, INC. (0000883107) (Filer)

Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and year ended December 31, 2025. "In 2025, we achieved record revenue of $62.1 million, effectively doubling our line of consumer products in just two years. This affirmed both the value we bring to the industry, and our ability to establish ourselves as a leading innovator and manufacturer of SPF-infused beauty products," said Kevin Cureton, President and Chief Executive Officer. "In November, we launc

ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2025 before the market opens on Tuesday, March 31, 2026, and host a conference call and webcast on the same date. Fourth Quarter 2025 Conference Call DetailsDate / Time: Tuesday, March 31, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin Cureton, President & CEO and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/btv3gq6b Dial-In Link: https://register-conf.media-server.com/re

Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoolie Park as Vice President of Brand Partnerships. In this role, Park will lead strategic relationships with emerging and established beauty brands, expanding Solésence's ability to deliver fully integrated, turnkey solutions that accelerate speed to market while enabling brands to deploy more working capital toward marketing and growth initiatives. "We are incredibly e